Digital The pulse of progress: AI, real-world data, and the ethics o... What kind of data should train and power the next generation of healthcare AI?
Market Access Innovation beyond invention will bring novel medicines to Eu... Unlocking the potential of novel medicines for Europe’s patients demands innovation beyond invention.
R&D The devil’s in the details: Navigating complexity & nuance i... Clinical trial expansion comes with complexity and increased risk, as each country has distinct regulatory requirements and contractual expectations.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.